|
|
Post by sportsrancho on May 11, 2021 16:10:07 GMT -5
UTHR is legit. The street probably assigns little to no value to the RLS collaboration. We’ve stopped pushing Afrezza. If Afrezza can make a comeback - ok, comeback isn’t the right word - or if VDEX can make Afrezza successful; and/or if RLS actually materializes, then shorts might decide to make their orderly exit. If VDEX could make Afrezza successful we would already know..... The fact that it hasn't tells you everything you need to know If Bill didn’t feel like he could help make Afrezza the success it should be we wouldn’t be expanding. That tells you everything you need to know:-) After all what you said is just like saying Mike/Mannkind would’ve already made it a success if they could have. But they are going on with pediatric, that tells you everything you need to know also. |
|
|
|
Post by morfu on May 11, 2021 16:45:45 GMT -5
Time to open another VDex channel.. the 3 (or 4??) we already have are obviously not enough..
I think in the real world the 10 top prescribers of Afrezza still report growing numbers!
Mannkind might not sell Afrezza as fast as some here dream, but it will get there..
While I look forward to the sales numbers tomorrow I am not sure what they really indicate as the world after Corona will be different.
And green numbers for Mannkind by 2023 are still possible even so the reason for that seems shifitng.
|
|
|
|
Post by falconquest on May 11, 2021 20:23:16 GMT -5
UTHR is legit. The street probably assigns little to no value to the RLS collaboration. We’ve stopped pushing Afrezza. If Afrezza can make a comeback - ok, comeback isn’t the right word - or if VDEX can make Afrezza successful; and/or if RLS actually materializes, then shorts might decide to make their orderly exit. If VDEX could make Afrezza successful we would already know..... The fact that it hasn't tells you everything you need to know Well phdedieu12, I would argue that no one understands Afrezza better than Vdex. Argue against that claim. If Mannkind is going to move Afrezza forward it is going to be through a dedicated clinic that understands the drug and how to get it approved by patients. Prove me wrong! Endo's don't have or take time to understand it. Dr. Mann was right when he said it is the best insulin to treat diabetes. |
|
|
|
Post by bones1026 on May 11, 2021 20:30:39 GMT -5
If VDEX could make Afrezza successful we would already know..... The fact that it hasn't tells you everything you need to know Well phdedieu12, I would argue that no one understands Afrezza better than Vdex. Argue against that claim. If Mannkind is going to move Afrezza forward it is going to be through a dedicated clinic that understands the drug and how to get it approved by patients. Prove me wrong! Endo's don't have or take time to understand it. Dr. Mann was right when he said it is the best insulin to treat diabetes. Hey, Bill 👋 Agree with everything you said. |
|
|
|
Post by falconquest on May 11, 2021 20:38:59 GMT -5
Well phdedieu12, I would argue that no one understands Afrezza better than Vdex. Argue against that claim. If Mannkind is going to move Afrezza forward it is going to be through a dedicated clinic that understands the drug and how to get it approved by patients. Prove me wrong! Endo's don't have or take time to understand it. Dr. Mann was right when he said it is the best insulin to treat diabetes. Hey, Bill 👋 Agree with everything you said. I have probably been called many things over the years but "Bill" was never one of them. I have a hunch Sports can vouch for me on that.........but nice try! |
|
|
|
Post by peppy on May 11, 2021 20:48:46 GMT -5
If VDEX could make Afrezza successful we would already know..... The fact that it hasn't tells you everything you need to know Well phdedieu12, I would argue that no one understands Afrezza better than Vdex. Argue against that claim. If Mannkind is going to move Afrezza forward it is going to be through a dedicated clinic that understands the drug and how to get it approved by patients. Prove me wrong! Endo's don't have or take time to understand it. Dr. Mann was right when he said it is the best insulin to treat diabetes. If Afrezza was covered by health insurance ENDO's would take time to understand it. Just sayin. (If there was money in it, they would take the weekend course.There I fixed it for myself.) |
|
|
|
Post by sportsrancho on May 11, 2021 20:51:06 GMT -5
Hey, Bill 👋 Agree with everything you said. I have probably been called many things over the years but "Bill" was never one of them. I have a hunch Sports can vouch for me on that.........but nice try! You know what’s really funny is who “liked” phd post... thought someone was going to say hi Mike😂 All kidding aside at least we’re on the right thread:-) |
|
|
|
Post by sportsrancho on May 11, 2021 20:54:42 GMT -5
What’s really disheartening is there is a real shortage of Endo’s and a real shortage of Endo’s who enjoy treating diabetes.
More insurance coverage would definitely help but I don’t think it’s the root cause.
|
|
|
|
Post by mytakeonit on May 11, 2021 20:54:58 GMT -5
The thing about falcon"Bill"quest is that he is always around holding the violin and I haven't heard a squeak out of it. So falcon ... this gift is for you. www.youtube.com/watch?v=SyoMvTgetGgBut, that's mytakeonit |
|
|
|
Post by peppy on May 11, 2021 21:00:58 GMT -5
The thing about falcon"Bill"quest is that he is always around holding the violin and I haven't heard a squeak out of it. So falcon ... this gift is for you. www.youtube.com/watch?v=SyoMvTgetGgBut, that's mytakeonit ok, that was funny. hey MTOI, $10 dollars in May? |
|
|
|
Post by falconquest on May 11, 2021 21:46:27 GMT -5
The thing about falcon"Bill"quest is that he is always around holding the violin and I haven't heard a squeak out of it. So falcon ... this gift is for you. www.youtube.com/watch?v=SyoMvTgetGgBut, that's mytakeonit Oh ye of feeble mind. Allow me to enlighten your senses for your lack of sophistication be known far and wide. Rather than dabble in such mediocrity allow me to take you right to the source and bedazzle you with the brilliance of Mr. Hugh Marsh. Knowing you require the merest elaboration on the performance, please pay particular attention to the call of the guitar and the response of the violin.
|
|
|
|
Post by mytakeonit on May 11, 2021 22:03:41 GMT -5
Okay people ... you all asked and I found out for you. Yes, falcon did complete his quest and became a famous violin player.
But, that's mytakeonit
peppy ... $10 will be when the MNKD and UTHR project starts. After that, it'll go to the moon. ... I hope !!!
|
|
|
|
Post by phdedieu12 on May 12, 2021 9:58:56 GMT -5
If VDEX could make Afrezza successful we would already know..... The fact that it hasn't tells you everything you need to know If Bill didn’t feel like he could help make Afrezza the success it should be we wouldn’t be expanding. That tells you everything you need to know:-) After all what you said is just like saying Mike/Mannkind would’ve already made it a success if they could have. But they are going on with pediatric, that tells you everything you need to know also. And when "Bill" has a "clinic"/location/desk everywhere or however you describe this expansion, and they drives the majority of sales, I'll agree with you. Afrezza will only be a success when endos prescribe it, A LOT, period. Your comparison is flawed at best, intellectually dishonest at worst. What I suggest is that if it could make Afrezza successful, we would see it in the numbers, and we don't. Unless you have data showing otherwise....and if so, please share. |
|
|
|
Post by phdedieu12 on May 12, 2021 10:14:15 GMT -5
If VDEX could make Afrezza successful we would already know..... The fact that it hasn't tells you everything you need to know Well phdedieu12, I would argue that no one understands Afrezza better than Vdex. Argue against that claim. If Mannkind is going to move Afrezza forward it is going to be through a dedicated clinic that understands the drug and how to get it approved by patients. Prove me wrong! Endo's don't have or take time to understand it. Dr. Mann was right when he said it is the best insulin to treat diabetes. And you might very well be right, it seems pretty evident that Vdex is a wonderful advocate to a wonderful product, and please note at no point did I say otherwise. What does "moving Afrezza forward" even means? You're of the belief that there is one path and one path alone, and the business model you describe suggests that we need dedicated clinics everywhere. I am not in 5th grade and have nothing to prove, but unless I am completely missing the mark, endos are still the ones prescribing. We may be frustrated with the lack of awareness, lack of interest/time from said endos to learn about this product, or desire to get their patients well beyond the current lousy standard of care, etc, but to think you'll be able to bypass endos through a dedicated system in order to MAKE AFREZZA succesful (which was my original comment), is simply not an opinion I share. |
|
|
|
Post by phdedieu12 on May 12, 2021 10:29:37 GMT -5
What’s really disheartening is there is a real shortage of Endo’s and a real shortage of Endo’s who enjoy treating diabetes. More insurance coverage would definitely help but I don’t think it’s the root cause. I very much agree with that thought, hopefully the company can find a way to incentivize those physicians, in adopting a drug that is a true market disruptor. That is not an easy task, as we all know. |
|
